Contaminant In Baxter Heparin Identified By FDA

March 19, 2008

The contaminant in Baxter International Inc’s blood thinning medication, heparin, which has led to the deaths of 19 people, has been identified by The Food and Drug Administration in the U.S.

The harmful addition to the medication has been identified as a chemical compound, quite similar to the intended drug, heparin, but is actually oversulfated chondroitin sulfate, which has never been approved by either the FDA or any other similar body internationally.

Comments